BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6945292)

  • 1. Possibly specific immune complexes in sera of patients with untreated acute myelogenous leukemia.
    Fäldt R; Ankerst J
    Int J Cancer; 1980 Sep; 26(3):309-14. PubMed ID: 6945292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies reactive with human myeloid leukaemia cells.
    Ball ED; Fanger MW
    Clin Exp Immunol; 1982 Jun; 48(3):655-65. PubMed ID: 6956470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody dependent cellular cytotoxicity and complement mediated cytotoxicity on leukemic cells mediated by anti K562 monoclonal antibodies.
    Tatake RJ; Maniar HS; Chiplunkar SV; Somasundaram R; Amin MK; Saikia T; Gangal SG
    J Clin Lab Immunol; 1990 Feb; 31(2):87-91. PubMed ID: 1966990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated humoral cytotoxicity in patients with acute myelogenous leukemia before and after chemotherapy.
    Fäldt R; Ankerst J
    Int J Cancer; 1977 Dec; 20(6):824-33. PubMed ID: 271142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the ability of monoclonal antibodies to selectively mediate complement-dependent cytotoxicity of human myelogenous leukemia blast cells.
    Ball ED; Kadushin JM; Schacter B; Fanger MW
    J Immunol; 1982 Mar; 128(3):1476-81. PubMed ID: 6948897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inability to demonstrate lytic antibodies to autologous leukaemia cells in the sera from remission patients with acute myelogenous leukaemia treated with active specific immunotherapy.
    Chapuis BJ; Powles R; Alexander P
    Clin Exp Immunol; 1978 May; 32(2):253-8. PubMed ID: 276431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 125I-protein A-binding assay detecting antibodies to cell surface antigens. Evidence for the presence of specific antibodies against leukemia-associated antigens in human leukemias.
    Fäldt R; Ankerst J
    Cancer Immunol Immunother; 1983; 15(2):69-77. PubMed ID: 6223693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of heteroantisera to human acute leukemia-associated antigens.
    Baker MA; Ramachandar K; Taub RN
    J Clin Invest; 1974 Dec; 54(6):1273-8. PubMed ID: 4140196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to primate retrovirus antigens in circulating immune complexes of patients with acute myeloid leukemia.
    Anh-Tuan N; Tóth FD; Szabó B; Kiss J; Réthy A; Falus A; Merétey K; Mód A; Füst G; Váczi L
    Leuk Res; 1984; 8(5):863-71. PubMed ID: 6593512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.
    Andreasen RB; Olsson L
    J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity of antisera to a myelogenous leukemia cell line with the Philadelphia chromosome.
    Whitson ME; Lozzio CB; Lozzio BB; Wust CJ; Sonoda T; Avery B
    J Natl Cancer Inst; 1976 May; 56(5):903-7. PubMed ID: 1069137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro tumoricidal activity of immunoadsorbed leukemic serum.
    Miller WJ; Branda RF
    J Biol Response Mod; 1984; 3(3):231-4. PubMed ID: 6379106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic antibody in acute myeloblastic leukaemia during immunotherapy: lack of tumour specificity.
    Gale DG; MacLennan IC
    Br J Cancer; 1977 Mar; 35(3):280-7. PubMed ID: 265730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein A adsorption of acute myelogenous leukemia serum induces in vitro blast lysis.
    Miller WJ; Branda RF; Hurd DD; Wachsman W; Nelson NL; Jacob HS
    Blood; 1982 Jun; 59(6):1344-7. PubMed ID: 7044448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human acute myelogenous leukemia-associated antigens defined by a monkey antiserum to glycoproteins shed from leukemia myeloblasts.
    Mohanakumar T; Giedlin MA; Baker MA; Roncari DA; Taub RN
    Leuk Res; 1981; 5(1):11-7. PubMed ID: 6939949
    [No Abstract]   [Full Text] [Related]  

  • 16. Demonstration of antibody-associated cellular cytotoxicity in patients with acute myelogenous leukemia before and after chemotherapy.
    Fäldt R; Ankerst J
    Int J Cancer; 1979 Jul; 24(1):17-26. PubMed ID: 289631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia-associated antigen associated with autoantibody response in a subset of patients.
    Ersvaer E; Zhang JY; McCormack E; Olsnes A; Anensen N; Tan EM; Gjertsen BT; Bruserud O
    Eur J Haematol; 2007 Sep; 79(3):210-25. PubMed ID: 17655707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic antibody in normal human serums reactive with tumor cells from acute lymphocytic leukemia.
    Bias WB; Santos GW; Burke PJ; Mullins GM; Humphrey RL
    Science; 1972 Oct; 178(4058):304-6. PubMed ID: 4116712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human acute myelogenous leukemia antigens defined by simian antisera: evidence for leukemia-associated antigens distinct from immune response-associated alloantigens.
    Mohanakumar T; Russell EC; Metzgar RS; Dunn N; Phibbs M; McWilliams NB; Maurer HM
    J Natl Cancer Inst; 1979 May; 62(5):1163-7. PubMed ID: 86633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute leukemia-associated antigens.
    Mann DL; Halterman R; Leventhal B
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1446-51. PubMed ID: 4370857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.